BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34108011)

  • 41. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
    Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
    PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
    Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
    Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis.
    Konishi K; Watanabe Y; Shen L; Guo Y; Castoro RJ; Kondo K; Chung W; Ahmed S; Jelinek J; Boumber YA; Estecio MR; Maegawa S; Kondo Y; Itoh F; Imawari M; Hamilton SR; Issa JP
    PLoS One; 2011; 6(11):e27889. PubMed ID: 22132162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
    Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
    Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
    Wang Y; Liu D; Jin X; Song H; Lou G
    Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide Analysis Reveals DNA Methylation Alterations in Obesity Associated with High Risk of Colorectal Cancer.
    Dong L; Ma L; Ma GH; Ren H
    Sci Rep; 2019 Mar; 9(1):5100. PubMed ID: 30911103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
    Sastre J; Orden V; Martínez A; Bando I; Balbín M; Bellosillo B; Palanca S; Peligros Gomez MI; Mediero B; Llovet P; Moral VM; Viéitez JM; García-Alfonso P; Calle SG; Ortiz-Morales MJ; Salud A; Quintero G; Lopez C; Díaz-Rubio E; Aranda E;
    Clin Colorectal Cancer; 2020 Sep; 19(3):e110-e116. PubMed ID: 32278676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Coppedè F; Lopomo A; Spisni R; Migliore L
    World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
    Li R; Qu B; Wan K; Lu C; Li T; Zhou F; Lin J
    FEBS Open Bio; 2021 Jul; 11(7):1941-1952. PubMed ID: 33955718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
    Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
    Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
    Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
    Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis.
    Liu J; Cho YB; Hong HK; Wu S; Ebert PJ; Bray SM; Wong SS; Ting JC; Calley JN; Whittington CF; Bhagwat SV; Reinhard C; Wild R; Nam DH; Aggarwal A; Lee WY; Peng SB
    Sci Rep; 2020 Jul; 10(1):10725. PubMed ID: 32612211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide methylation analyses identifies Non-coding RNA genes dysregulated in breast tumours that metastasise to the brain.
    Pangeni RP; Olivaries I; Huen D; Buzatto VC; Dawson TP; Ashton KM; Davis C; Brodbelt AR; Jenkinson MD; Bièche I; Yang L; Latif F; Darling JL; Warr TJ; Morris MR
    Sci Rep; 2022 Jan; 12(1):1102. PubMed ID: 35058523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
    Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
    Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.